Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | ACACB | O00763 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28052416 | 0.77 | TSHR (0.40) | TSHRACACBALDH1A1MAPK1TDP1 | |
| SCHEMBL11320958 | 0.77 | TSHR (0.38) | TSHRALDH1A1HPGD | |
| SCHEMBL771037 | 0.76 | TSHR (0.41) | TSHRALDH1A1MAPK1HPGD | |
| SCHEMBL4759787 | 0.76 | TSHR (0.50) | TSHRACACBALDH1A1MAPK1TDP1 | |
| SCHEMBL6245506 | 0.74 | TSHR (0.48) | TSHRACACBALDH1A1MAPK1TDP1 | |
| SCHEMBL1038644 | 0.74 | TSHR (0.44) | TSHRALDH1A1MAPK1HPGD | |
| SCHEMBL9746908 | 0.74 | TSHR (0.54) | TSHRACACBALDH1A1MAPK1TDP1 | |
| SCHEMBL7757770 | 0.74 | TSHR (0.58) | TSHRACACBALDH1A1MAPK1TDP1 | |
| SCHEMBL13370836 | 0.71 | TSHR (0.45) | TSHRACACBALDH1A1MAPK1TDP1 | |
| SCHEMBL5843329 | 0.71 | TSHR (0.50) | TSHRACACBALDH1A1MAPK1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120052039-A1 | Organosilicones | THE PROCTER & GAMBLE COMPANY | 2012-03-01 | — | — | US | disclosed |
| US-20110240065-A1 | CARE POLYMERS | THE PROCTER & GAMBLE COMPANY | 2011-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120052039-A1 | Organosilicones | NISCH, XRCC6, RAD50 | TSHR 4805/4885ACACB 2039/4885ALDH1A1 2605/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.